In summary, we found that PRR11-mediated activation of the AKT pathway affects oxidative DNA damage and accelerates RCC progression via a molecular mechanism in which FBXW7-GSK3β mediates PRR11 degradation. Here, AKT1 is linked to renal cell carcinoma.